Retatrutide is an investigational triple agonist acting on GLP-1, GIP, and glucagon receptors a mechanism distinct from approved agents such as semaglutide or tirzepatide
This may support reduced calorie intake and gradual weight loss when combined with healthy lifestyle habits
For individuals who often feel fatigued or lethargic, these injections can provide a much-needed boost
Diet pills focus on suppressing appetite or increasing metabolism, whereas GLP-1 agonists work by mimicking the action of the GLP-1 hormone that is naturally produced in the body and plays a crucial role in regulating appetite and blood sugar levels
Additionally, the concomitant use of semaglutide with other type 2 diabetes medications, such as insulin or sulfonylureas, which promote weight gain may also reduce the weight loss effect
This dangerous combination means you cannot rely on thirst as a hydration indicator